Biobide shows new researches about zebrafish in the European Zebrafish Meeting

Bionaturis Group company expert in the use of zebrafish as alternative animal model, Biobide, will present new studies about the versatility of this specie for toxicity, security and efficacy assays of new compounds in the 10th European Zebrafish Meeting in Budapest. The event -held from 3 to 7th, June- will gather the specialists of this increasing sector.

read more

Bionaturis acquires BBD BIOPHENIX S.L.

Bionaturis (ticker BNT-MAB), an international reference company developing biological drugs, has just acquired the San Sebastian-based company BBD BIOPHENIX S.L (BBD), a leader in state-of-the-art screening systems for drug discovery. With this acquisition Bionaturis incorporates cutting-edge biotech assets to its organic growth, in this case, related to the use of zebra fish models for early determination of drug pharmacological profiles.

read more